Modulation of cytokine production by 7-hydroxycoumarin in vitro and its efficacy against influenza infection in mice

Antiviral Research

Volumn 85, Issue 2, 2010, Pages 373-380

  Kurokawa, Masahiko ^a   Watanabe, Wataru ^a   Shimizu, Tomomi ^a   Sawamura, Rie ^a   Shiraki, Kimiyasu ^b  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

7 Hydroxycoumarin; Cytokines; Influenza infection; Lung; Mouse

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UMBELLIFERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SURVIVAL TIME; TH1 CELL; VIROGENESIS; VIRUS TITRATION; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CYTOKINES; FEMALE; IMMUNOLOGIC FACTORS; LUNG; MACROPHAGES; MICE; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; UMBELLIFERONES;

MURINAE; MUS; ORTHOMYXOVIRIDAE;

EID: 74449092526     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.11.001     Document Type: Article

References (44)

1. Aldridge, Moseley C.E., Boltz D.A., Negovetich N.J., Reynolds C., Franks J., Brown S.A., Doherty P.C., Webster R.G., and Thomas P.G. TNF/iNOS-producing dendric cells are the necessary evil of lethal influenza virus infection. Proc. Natl. Acad. Sci. USA 106 (2009) 5306-5311
2. Ansell J., and Bergqvist D. Current options in the prevention of thromboembolic disease. Drugs 64 Suppl. 1 (2004) 1-5
3. Arulanandam B.P., O'Toole M., and Metzger D.W. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. J. Infect. Dis. 180 (1999) 940-949
4. Barbour S.E., Wong C., Rabah D., Kapur A., and Carter A.D. Mature macrophage cell lines exhibit variable responses to LPS. Mol. Immunol. 35 (1998) 977-987
5. Cheung C.Y., Poon L.L., Lau A.S., Luk W., Lau Y.L., Shortridge K.F., Gordon S., Guan Y., and Peiris J.S. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 360 (2002) 1831-1837
6. Conn C.A., McClellan J.L., Maassab H.F., Smitka C.W., Majde J.A., and Kluger M.J. Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 268 (1995) R78-R84
7. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., Hoang D.M., Chau N.V., Khanh T.H., Dong V.C., Qui P.T., Cam B.V., Ha do Q., Guan Y., Peiris J.S., Chinh N.T., Hien T.T., and Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12 (2006) 1203-1207
8. Deliyannis G., Jackson D.C., Ede N.J., Zeng W., Hourdakis I., Sakabetis E., and Brown L.E. Induction of long-term memory CD8+ T cells for recall of viral clearing responses against influenza virus. J. Virol. 76 (2002) 4212-4221
9. Fritz R.S., Hayden F.G., Calfee D.P., Cass L.M., Peng A.W., Alvord W.G., Strober W., and Straus S.E. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J. Infect. Dis. 180 (1999) 586-593
10. Ginsberg H.S., and Horsfall Jr. F.L. Quantitative aspects of the multiplication of influenza A virus in the mouse lung; relation between the degree of viral multiplication and the extent of pneumonia. J. Exp. Med. 95 (1952) 135-145
11. Hennet T., Ziltener H.J., Frei K., and Peterhans E. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J. Immunol. 149 (1992) 932-939
12. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., and Murphy K.M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260 (1993) 547-549
13. Kaiser L., Fritz R.S., Straus S.E., Gubareva L., and Hayden F.G. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J. Med. Virol. 64 (2001) 262-268
14. Kash J.C., Tumpey T.M., Proll S.C., Carter V., Perwitasari O., Thomas M.J., Basler C.F., Palese P., Taubenberger J.K., García-Sastre A., Swayne D.E., and Katze M.G. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443 (2006) 578-581
15. Koren H.S., Handwerger B.S., and Wunderlich J.R. Identification of macrophage-like characteristics in a cultured murine tumor line. J. Immunol. 114 (1975) 894-897
16. Kos F.J., and Engleman E.G. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell. Immunol. 173 (1996) 1-6
17. Kurokawa M., Ochiai H., Nakajima K., and Niwayama S. Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus. J. Gen. Virol. 71 (1990) 2149-2155
18. Kurokawa M., Imakita M., Kumeda C.A., and Shiraki K. Cascade of fever production in mice infected with influenza virus. J. Med. Virol. 50 (1996) 152-158
19. Kurokawa M., Imakita M., Kumeda C.A., Yukawa T.A., and Shiraki K. Kakkon-to suppressed interleukin-1α production responsive to interferon and alleviated influenza infection in mice. J. Tradit. Med. 13 (1996) 201-209
20. Kurokawa M., Hozumi T., Basnet P., Nakano M., Kadota S., Namba T., Kawana T., and Shiraki K. Purification and characterization of eugeniin as an anti-herpes virus compound from Geum japonicum and Syzygium aromaticum. J. Pharmacol. Exp. Ther. 284 (1998) 728-735
21. Kurokawa M., Kumeda C.A., Yamamura J., Kamiyama T., and Shiraki K. Antipyretic activity of cinnamyl and related compounds in influenza virus-infected mice. Eur. J. Pharm. 348 (1998) 45-51
22. Kurokawa M., Basnet P., Ohsugi M., Hozumi T., Kadota S., Namba T., Kawana T., and Shiraki K. Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo. J. Pharmacol. Exp. Ther. 289 (1999) 72-78
23. Kurokawa M., Hozumi T., Tsurita M., Kadota S., Namba T., and Shiraki K. Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo. J. Pharmacol. Exp. Ther. 297 (2001) 372-379
24. Kurokawa M., Tsurita M., Brown J., Fukuda Y., and Shiraki K. Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice. Antiviral Res. 56 (2002) 183-188
25. Kurokawa M., Brown J., Kagawa Y., and Shiraki K. Cytokine-regulatory activity and therapeutic efficacy of cinnamyl derivatives in endotoxin shock. Eur. J. Pharm. 474 (2003) 283-293
26. Maeda H., and Akaike T. Oxygen free radicals as pathogenic molecules in viral diseases. Proc. Soc. Exp. Biol. Med. 198 (1991) 721-727
27. Manetti R., Gerosa F., Giudizi M.G., Biagiotti R., Parronchi P., Piccinni M.P., Sampognaro S., Maggi E., Romagnani S., and Trinchieri G. Interleukin-12 induces stable priming for interferon-γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J. Exp. Med. 179 (1994) 1273-1283
28. Monteiro J.M., Harvey C., and Trinchieri G. Role of interleukin-12 in primary influenza virus infection. J. Virol. 72 (1998) 4825-4831
29. Nagasaka K., Kurokawa M., Imakita M., Terasawa K., and Shiraki K. Efficacy of Kakkon-to, a traditional herb medicine, in herpes simplex virus type 1 infection in mice. J. Med. Virol. 46 (1995) 28-34
30. Ochiai H., Kurokawa M., Hayashi K., and Niwayama S. Antibody-mediated growth of influenza A NWS virus in macrophage-like cell line P388D1. J. Virol. 62 (1988) 20-26
31. Oda T., Akaike T., Hamamoto T., Suzuki F., Hirano T., and Maeda H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244 (1989) 974-976
32. Paul W.E., and Seder R.A. Lymphocyte responses and cytokines. Cell 76 (1994) 241-251
33. Peiris J.S., Yu W.C., Leung C.W., Cheung C.Y., Ng W.F., Nicholls J.M., Ng T.K., Chan K.H., Lai S.T., Lim W.L., Yuen K.Y., and Guan Y. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363 (2004) 617-619
34. Peper R.L., and Van Campen H. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb. Pathog. 19 (1995) 175-183
35. Robertson M.J., Soiffer R.J., Wolf S.F., Manley T.J., Donahue C., Young D., Herrmann S.H., and Ritz J. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175 (1992) 779-788
36. Sato K., Suga M., Akaike T., Fujii S., Muranaka H., Doi T., Maeda H., and Ando M. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. Am. J. Respir. Crit. Care Med. 157 (1998) 853-857
37. Shimizu T., Hino A., Tsutsumi A., Park Y.K., Watanabe W., and Kurokawa M. Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice. Antivir. Chem. Chemother. 19 (2008) 7-13
38. Snyderman R., Pike M.C., Fischer D.G., and Koren H.S. Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1. J. Immunol. 119 (1977) 2060-2066
39. Swiergiel A.H., and Dunn A.J. The roles of IL-1, IL-6, and TNFalpha in the feeding responses to endotoxin and influenza virus infection in mice. Brain Behav. Immun. 13 (1999) 252-265
40. Szretter K.J., Gangappa S., Lu X., Smith C., Shieh W.-J., Zaki S.R., Sambhara S., Tumpey T.M., and Katz J.M. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol. 81 (2007) 2736-2744
41. Tsurita M., Kurokawa M., Imakita M., Fukuda Y., Watanabe Y., and Shiraki K. Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. J. Pharmacol. Exp. Ther. 298 (2001) 362-368
42. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet. Microbiol. 74 (2000) 109-116
43. Xu T., Qiao J., Zhao L., Wang G., He G., Li K., Tian Y., Gao M., Wang J., Wang H., and Dong C. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am. J. Respir. Crit. Care Med. 174 (2006) 1011-1017
44. Yuen K.Y., Chan P.K., Peiris M., Tsang D.N., Que T.L., Shortridge K.F., Cheung T., To W.K., Ho E.T., Sung R., and Cheng A.F. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351 (1998) 467-471